Literature DB >> 6479607

Papilloedema in late-onset citrullinaemia: report of second case.

S Hayasaka, K Yabata, M Ohmura, H Nomura, S Takase.   

Abstract

A young adult patient suddenly began to have episodes of unconsciousness that each lasted for several hours. Brief episodes of lethargy occurred monthly. Biochemical tests disclosed high levels of ammonia and citrulline in the serum. Brain oedema was suggested by CT scan, and optic disc swelling was observed ophthalmoscopically, indicating papilloedema. He died in coma. Deficient activity of argininosuccinate synthetase in the liver was demonstrated. Papilloedema was confirmed histologically. We believe that papilloedema is a serious sign indicating poor prognosis in late-onset citrullinaemia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6479607     DOI: 10.1007/bf02134120

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  5 in total

1.  [Juvenile hepatocerebral disease with citrullinemia].

Authors:  K Imanishi; T Okajima; T Ideta; H Ueno; Y Matsumoto
Journal:  Rinsho Shinkeigaku       Date:  1976-05

2.  [An autopsy case of juvenile hepato-cerebral degeneration (non-Wilsonian Inose-type) with mental retardation, with special reference to ammonia and amino acids metabolism (author's transl)].

Authors:  M Takamizawa; M Toru; T Kojima; A Watanabe; K Hirokawa
Journal:  Seishin Shinkeigaku Zasshi       Date:  1973-06

3.  [Hepatic encephalomyelopathy associated with citrullinaemia].

Authors:  M Miyazaki; J Fukuda; M Aki; T Ezawa; M Kitamura
Journal:  No To Shinkei       Date:  1971-01

4.  Papilledema in late-onset citrullinemia.

Authors:  S Hayasaka; M Kiyosawa; H Nomura; S Takase
Journal:  Am J Ophthalmol       Date:  1984-02       Impact factor: 5.258

5.  Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia.

Authors:  T Saheki; A Ueda; M Hosoya; K Kusumi; S Takada; M Tsuda; T Katsunuma
Journal:  Clin Chim Acta       Date:  1981-02-05       Impact factor: 3.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.